Detalles de la búsqueda
1.
Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial.
J Infect Dis
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557639
2.
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
N Engl J Med
; 379(2): 138-149, 2018 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29996082
3.
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.
Am J Respir Crit Care Med
; 199(2): 220-231, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30092143
4.
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
Am J Respir Crit Care Med
; 195(9): 1171-1180, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28060545
5.
Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study.
Lancet Microbe
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729196
6.
HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV.
JHEP Rep
; 5(11): 100885, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37791379
7.
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
Lancet Infect Dis
; 22(6): 857-866, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35305317
8.
Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial.
EBioMedicine
; 82: 104138, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35809371
9.
Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
PLoS One
; 16(6): e0252808, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34097715
10.
Preferred product characteristics for therapeutic vaccines to improve tuberculosis treatment outcomes: Key considerations from World Health Organization consultations.
Vaccine
; 38(2): 135-142, 2020 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733944
11.
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.
EClinicalMedicine
; 21: 100313, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32382714
Resultados
1 -
11
de 11
1
Próxima >
>>